Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses …
Can Moderna’s Aggressive Cost Cuts Help Turn Things Around for Its Stock?
view original post